NCT01200992
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 30, 2010
Completion: Dec 31, 2013